Melanoma Institute Australia

The Viertel Charitable Foundation Fellowship
2026-03-31 23:59 (Australia/Sydney)
The Sylvia & Charles Viertel Charitable Foundation invites applications for the Senior Medical Research Fellowships valued at $275,000 per annum (total $1,375,000 over 5 years) to commence in 2027.
This funding opportunity is designed to support:

early to mid-career researchers qualified to at least the post-doctoral level (no more than 10 years post-doc, taking into account career disruptions);
who are outstanding researchers;
who do not currently hold a senior research or teaching position;
who are medically qualified, or PhD graduates of another scientific discipline with recognised post-doctoral achievements;
who are seeking to establish a research career in Australia and undertake research in an Australian academic institution; and
who are either an Australian citizen or permanent resident of Australia, or a New Zealand citizen with a Special Category (subclass 444) visa.

Key Dates
Applications close: 31 March 2026 11:59pm (AEST)
SEE GRANT GUIDELINES PDFAPPLY HERESEE WEBSITE

MRFF 2025 Clinical Trials Activity
2026-04-01 17:00 (Australia/Sydney)
The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative aims to:

improve the evidence base supporting clinical care
help patients access trials relevant to their health circumstances
enable researchers to bring international trials to Australian patients.

The Medical Research Future Fund (MRFF) – 2025 Clinical Trials Activity Grant Opportunity will support medical research and medical innovation projects that:

Stream 1 (Incubator): conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer, rare disease and/or unmet need.
Stream 2 (Targeted Call for Research): conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers, rare diseases and/or unmet need.
Stream 3 (Targeted Call for Research): conduct a clinical trial that supports the delivery of effective and high value care by targeting evidence gaps of value to health technology assessment processes in Australia.
Stream 4 (Targeted Call for Research): conduct a prevention clinical trial aimed at reducing the risk, onset or progression of disease through early intervention strategies.

The intended outcome of the research is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.
This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing.
Key Dates
Minimum data due date: 4 March 2026
Applications close: 1 April 2026
Funding anticipated to be awarded from December 2026
SEE GRANT GUIDELINESSEE WEBSITE

NHMRC Synergy Grants
2026-04-01 17:00 (Australia/Sydney)
Synergy Grants support outstanding multidisciplinary teams of investigators to work together to answer major questions that cannot be answered by a single investigator.
The intended outcomes of the Synergy Grant scheme are:

multidisciplinary research that addresses major problems in all areas of human health and medical research, from discovery to translation
highly collaborative teams of diverse researchers including by gender, career stage and cultural background, working together to address major problems in human health.

Synergy Grants may be funded by, or in conjunction with, other organisations. These grants offer opportunities to researchers whose work is relevant to the priorities and research interests of the partner organisations.
Key Dates
Minimum data: 4 March 2026 17:00 AEST
Applications close: 1 April 2026 17:00 AEST
Outcomes: October 2026
SEE WEBSITE

ARC Linkage Infrastructure, Equipment and Facilities
2026-04-09 17:00 (Australia/Sydney)
The Linkage Infrastructure, Equipment and Facilities (LIEF) scheme provides funding to eligible organisations for research infrastructure, equipment and facilities.
Under this scheme researchers participate in cooperative initiatives so that expensive research infrastructure, equipment and facilities can be shared between higher education organisations and industry.
The scheme fosters collaboration through its support of the cooperative use of international or national research facilities.
Applicants may seek funding for:

infrastructure, equipment and facility purchases, construction and installation
salaries directly associated with creating and installing infrastructure, equipment or facilities
leasing of infrastructure, equipment or facilities
consortium membership costs, in the case of Australia’s participation in the use of significant international-scale or national research facilities
specialised computing facilities and software
compilations, catalogues, clearing houses or bibliographies.

This scheme is intended to support researchers from higher education organisations and industry to gain access to the infrastructure, equipment and facilities that they need to carry out their research. The scheme provides funding to eligible organisations to purchase, construct or access expensive research infrastructure.
Key Dates
Applications close: 9 April 2026
Announcement: 22 December 2026 – 16 March 2027
SEE GRANT GUIDELINES PDFSEE WEBSITE

ARC Discovery Projects
2026-04-22 17:00 (Australia/Sydney)
Discovery Projects for funding commencing in 2027 will be run in a two-stage application process, commencing with an Expression of Interest (EOI). Shortlisted applicants will be invited to submit a full application.
Discovery Projects may be undertaken by individual researchers or research teams to:

expand knowledge base and research capacity in Australia, and
economic, commercial, environmental, social and/or cultural benefits for Australia.

Discovery Projects are for funding between $30,000 and $500,000 each year for up to 5 consecutive years. Project funding may be used for:

personnel, for example, research associates or assistants and technicians and stipends for higher degree by research students
teaching relief
access to research and infrastructure facilities and technical workshop services
essential field research
expert third party services
equipment and consumables
publication and dissemination of outputs and outreach
specialised computer equipment and software
travel costs essential to the project
web hosting and development
workshops, focus groups and conferences, and
essential support costs for researchers who are carers or who personally require care or assistance.

Key Dates
EOI Close: 12 December 2025
EOI Outcomes Announced: 25 February to 27 February 2026
Full Application Open: 2 March 2026
Full Application Close: 22 April 2026
Rejoinders: 23 June to 6 July 2026
Anticipated announcement: 19 October to 30 October 2026
SEE GRANT GUIDELINES PDFSEE GRANT GUIDELINES CHANGES PDFSEE WEBSITE

Australian Melanoma Research Foundation Research Grants
2026-04-30 17:00 (Australia/Sydney)
The AMRF will continue to support the next generation of melanoma researchers in Australia by providing research grants to post-graduate students and early career researchers.
The AMRF will fund research that contributes to the understanding and prevention of melanoma. The number of grants awarded in 2026 will depend on the quality of the applications and the funds requested. The AMRF will be selective in the research it supports. Any proposal to the Foundation for research funding will need to be contestable and show evidence of scientific merit within the national context.
The aim of the AMRF’s grants scheme is to support high quality research that is not fully funded through other grant schemes or from other sources. AMRF funds are to be applied to offset the direct costs of the research. The proposed research may be part of an existing research program. However, the application to the AMRF should be for a stand-alone component of that existing project.
Applications for funding will be assessed against several of the following criteria:

Publication history in melanoma (by the applicant and/or their supervisor)
Evidence of scientific merit and clinical need within the national context
Proposed dissemination of research findings
Broader impact on education and awareness of melanoma

Key Dates
EOIs close: 30 April 2026
Full applications deadline: 25 May 2026
Successful applicants announced: 15 June 2026
Funds available: by 30 June 2026
SEE GRANT GUIDELINESSEE WEBSITE

NSW Translational Research Grants Scheme
2026-04-30 17:00 (Australia/Sydney)
Funding research projects that translate into better patient outcomes, health service delivery, and population health and wellbeing
The Translational Research Grants Scheme aims to:

foster the generation of high-quality research that is directly relevant to clinical, health service and population health practice in NSW
enhance health and medical research capability and capacity within the NSW health system
support projects that have the potential to be translated into policy and practice, including research that can be generalised and scaled in other LHDs/SHNs across the state
reduce the time from evidence generation to practice implementation.

Host organisations must identify and engage relevant partners to support effective delivery of the research project and implementation of the outcomes in NSW.
Round 10 NOW OPEN.
Key Dates
EOI due to Host Organisation: 30 April 2026
Full application due to Host Organisation: 31 July 2026
Full applications due to NSW Ministry of Health, Office for Health and Medical Research: 28 August 2026
Successful applicants notified: Late February 2027
Research begins: 1 July 2027
SEE GRANT GUIDELINESSEE WEBSITE

NHMRC Ideas Grants
2026-05-06 17:00 (Australia/Sydney)
The objective of the Ideas Grant scheme is to support innovative research projects addressing a specific question(s).
The expected outcomes are:

innovative and creative research
funding of researchers at all career stages
funding any area of health and medical research from discovery to implementation.

It is expected that the Chief Investigator A (CIA) will have the capability to lead the team in achieving the project aims.
The Ideas Grant scheme is not intended to support research where a clinical trial or cohort study is the primary objective. Applicants conducting projects which incorporate elements of clinical trial and/or cohort study must consider whether the project goals are more applicable to the Ideas Grant or Clinical Trials and Cohort Grant schemes.
Ideas Grants may be funded by or in conjunction with other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations. The amount of funding for an Ideas Grant is based on assessment of the requested budget.
Key Dates
Applications open: 11 March 2026
Minimum data due date: 8 April 2026
Applications close: 6 May 2026
Proposed peer review: June to September 2026
SEE WEBSITE

Cancer Council NSW Project Grant
2026-05-06 17:00 (Australia/Sydney)
Applications for Cancer Council NSW and Cancer Council SA funding are aligned with the National Health and Medical Research Council’s Ideas Grants submission and review processes.
Cancer Council NSW Project Grants are:

open to research projects on any aspect of cancer, including its causes, mechanisms, prevention, treatment and care, and the organisation and performance of cancer control services
awarded for up to three years
valued up to $600,000 over three years
open to all Australian cancer researchers.

Researchers wishing to apply for Cancer Council NSW Project Grants must complete:

NHMRC Ideas Grant application. In the Sapphire application, please select ‘Cancer Council’ as a funding option
Submission of a Cancer Council NSW application through our grants portal, which includes Lived Experience targeted questions.

Key Dates
NHMRC Ideas Grant/Cancer Council Project Grant applications open: 13 March 2026
Minimum data due for NHMRC Ideas Grant via Sapphire: 8 April 2026
Closing date for NHMRC Ideas Grant applications via Sapphire: 6 May 2026
Closing date for submission of Cancer Council Project Grants application: 22 May 2026
Cancer Council advises applicants of funding outcomes: February 2027
SEE GRANT GUIDELINESSEE WEBSITE

ACRF Annual Research Grants
2026-05-22 17:00 (Australia/Sydney)
Australian Cancer Research Foundation (ACRF) awards capital grants (between $1.5 to $5 million) for technology, equipment and infrastructure for cancer research at Australian medical research institutes, hospitals and universities.
Grant applications are open to research into all types of cancer with a research focus on detection, prevention, and/or treatment.
Since 1984, ACRF has awarded $209.3 million to 93 research grants in 44 Australian cancer research institutes.
ACRF promotes collaboration amongst researchers and clinicians and encourages novel and innovative cancer research projects. All applications are competitively reviewed by the ACRF Medical Research Advisory Committee (MRAC) who recommend the best projects to the ACRF Board of Trustees for funding.
Key Dates
Applications close: 5:00pm, Friday 22 May 2026
SEE GRANT GUIDELINESSEE WEBSITE

Perpetual Ramaciotti Medal for Excellence in Biomedical Research
2026-05-29 17:00 (Australia/Sydney)
The Ramaciotti Medal is an annual award of $50,000. The Medal honours an individual who has made an outstanding discovery (or discoveries) in clinical or experimental biomedical research that has had an important impact on biomedical science, clinical science, or the way in which healthcare is delivered.
To be eligible for the Ramaciotti Medal, the greater part of the nominee’s work leading to the discovery (or discoveries) must have been conducted in Australia and they must still be actively engaged in this work.
The applicant must be peer nominated and the final recipient is selected based on a recommendation by the Ramaciotti Foundations Scientific Advisory Committee to Perpetual. Many past winners are highly regarded individuals in the top echelon of the biomedical research industry.
Key Dates
Applications close: Friday 29 May 2026, 5pm AEST
Applicants advised of outcome: September 2026
Recipients announced: October 2026
SEE GRANT GUIDELINESSEE WEBSITE

Perpetual Ramaciotti Health Investment Grants
2026-05-29 17:00 (Australia/Sydney)
Ramaciotti Health Investment grants of up to $100,000 are awarded to individuals in universities, public hospitals or institutes for a contribution towards the undertaking of health or medical research with the potential path to clinical application within five years. A Health Investment grant is intended to provide enabling research support for an autonomous early career investigator who is taking, or has recently taken, a substantive position.
Grants are awarded by Perpetual, Trustee of the Foundations, on the recommendation of a dedicated Scientific Advisory Committee.
In 2026 The Ramaciotti NSW Foundation will award up to six grants and The Ramaciotti Australia Foundation up to four grants. The Ramaciotti Australia Foundation supports organisations outside of NSW.
Key Dates
Applications close: Friday 29 May 2026, 5pm AEST
Applicants advised of outcome: September 2026
Recipients announced: October 2026
SEE GRANT GUIDELINESSEE WEBSITE

The Viertel Charitable Foundation Clinical Investigator Awards
2026-05-30 17:00 (Australia/Sydney)
Establishment grants for Clinical Investigators have been initiated by the Foundation in order to stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment. Clinical Investigators are awarded a once only grant of $90,000.
Eligible applicants will be medical graduates or graduates of other clinical disciplines who have completed both their clinical and research training which will normally be at doctoral level and are commencing their first definitive clinical position, or have been in such a post for no more than 36 months on 1 May of the year of application.
Applicants should be actively engaged in clinical work and pursuing health and medical research in a university clinical department, a teaching hospital, a clinical research unit of a research institute or in an academic general practice setting. The applications will be judged predominantly on the quality of the applicant’s track record and career achievements to date. The quality of a brief research proposal will also be taken into account.
Key Dates
Applications open: 6 April 2026
Applications close: 30 May 2026
The Guidelines will be available here when the round opens.
SEE GRANT GUIDELINESSEE WEBSITE

NHMRC Postgraduate Scholarships
2026-06-03 17:00 (Australia/Sydney)
The National Health and Medical Research Council (NHMRC) Postgraduate Scholarships scheme funds successful applicants to attain a research based postgraduate degree – Doctor of Philosophy (PhD) or a Research Masters Degree.

It aims to support these outstanding health and medical graduates early in their career so they can be trained to conduct research that is internationally competitive and develop a capacity for original independent research within Australia.
The intended outcome of the Postgraduate Scholarships scheme is increased research capacity within Australia.
Postgraduate Scholarships may be funded by, or in conjunction with, other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations.

Key Dates
Applications open: 8 April 2026
Minimum data due date: 13 May 2026
Applications close: 3 June 2026
Proposed peer review: July/August 2026
The Guidelines will be available here when the round opens.
SEE GRANT GUIDELINESSEE WEBSITE

SNOW MEDICAL Snow Fellowship
2026-06-04 17:00 (Australia/Sydney)
Snow Fellowships target emerging global research leaders that show the potential to drive, manage and influence the next generation of health and medical innovation. The Fellowship provides these emerging leaders the independence, funding and time to develop a bold research program, build their research team, and establish leadership experience.
Each Snow Fellowship will be valued at approximately $8 million over eight years for eligible early to mid-career researchers. Fellowship funding will be available to set up and operate a research laboratory, comprising salaries for the Snow Fellow and post doctoral researchers, PhD student scholarship top-ups, technical and laboratory management support, project funds and leadership development.
The Snow Fellowship program supports ambitious research and high-performing teams, and we believe that these are based on diversity, inclusivity and gender equality.
Snow Fellowship
Biomedical research
Up to $1M per year
8 years of funding (review at year 4/5)
Mentorship, leadership and management training support
Key Dates
Expression of Interest closes: 4 June 2026
Full Application opens (via invitation): 1st week of August 2026
Full Application closes: 1 October 2026
Interview: early February 2027
SEE GRANT GUIDELINESSEE WEBSITE

NSW Health Medical Devices Fund
2026-06-09 17:00 (Australia/Sydney)
The Medical Devices Fund provides grants to drive the commercialisation of highly innovative new devices and technologies in NSW, addressing gaps in the product life cycle between early-stage research and mature investment opportunities.

The Medical Devices Fund aims to:

Support individuals, companies, public and private hospitals, medical research institutes, universities, other public sector research organisations, and the medical devices industry, to take local innovation to market

Increase the uptake of NSW medical devices that are cost effective and contribute to improved patient outcomes.

For Round 14, applicants with projects that address the following NSW Health Research and Innovation Strategy aligned priorities are encouraged to apply:

Women’s Health
Female Entrepreneurs
Aboriginal Health

Applicants with projects that do not address the above priorities are also able to apply.

The program funds project activities used for any purpose that meets the objectives of the program, subject to the exclusions below.
Examples of activities that can be funded include:

device development, including proof-of-concept, prototyping, and piloting studies

manufacturing samples for product trials

clinical assessment

locating other national and international trials and research relevant to the product under development

business planning, including conducting market and product assessments

intellectual property management

commercialisation

capital raising

Key Dates:
Preliminary applications close: 9 June 2026, 5:00pm AEST
Full applications for this grant are by invitation only.
Notification of final outcomes: February 2027
SEE GRANT GUIDELINESSEE WEBSITE

SHP Annual Awards
2026-06-17 17:00 (Australia/Sydney)
Sydney Health Partners Awards celebrate outstanding early career researchers, clinician researchers, and consumers who are creating lasting impact in clinical and health services research. Award winners will be announced at the upcoming SHP Annual Forum on 29 July 2026.

Award Categories

Early career researchers and clinician researchers can apply or be nominated for one of five Awards:

Translational Research Addressing a Health Priority
Clinical Trial Excellence
Excellence in Consumer-Researcher Partnerships
Researcher–Health Professional Collaborations
SHP Using Research to Change Health Practice

Each Award winner will receive funding of $2,000 for:

research-related professional development expenses, and/or
payments for consumers partnering in research.

Nominees for the early career researchers and clinician researcher awards must be employed by a Sydney Health Partner organisation.

Consumer Contributions to Health Research

This consumer-focused award recognises the valued contribution of consumers who are actively involved in shaping health research that matters. Consumers can either self-nominate or be nominated by others.
The Consumer Award includes a gift card to the value of $250.
All nominations must include endorsement from a senior manager or researcher employed by a Sydney Health Partner organisation.

Nominate Now:

Nominations for the 2026 SHP Awards are now open and will close at 5:00pm AEST on Wednesday, 17th June 2026.

SEE GRANT GUIDELINESSEE WEBSITE

SHP Pilot Grants
2026-07-03 17:00 (Australia/Sydney)
SHP Pilot Grants – Funding to Test and Implement Research Into Clinical Practice
Each year, Sydney Health Partners funds pilot projects that help clinicians, researchers and health professionals turn evidence into practical healthcare solutions and scale up the implementation of research for broader impact.
If you’re a health professional, clinician, or researcher leading research within Sydney Health Partners’ affiliated health services, a Pilot Grant could help you to:

Test real-world implementation of research innovations
Solve complex health system challenges with practical solutions
Strengthen applications for major funding bodies (NHMRC, MRFF, TRGS)

Applications are now open for Sydney Health Partners 2026 Implementation Science Pilot Grants.
Sydney Health Partners are offering up to $220,000 in grants to support up to 11 pilot projects, with two of the projects to be funded by the Charles Perkins Centre Implementation Hub through the Jennie Mackenzie Research Fund.
Grant Categories:
Stream 1: SHP Implementation Science Pilot Grants (up to 9)
These grants require two Principal Investigators (PIs):

One from the University of Sydney or an SHP Partner Medical Research Institute (MRI)

One from an SHP Health Service Partner

Stream 2: CPC Implementation Hub Pilot Grants (x2)
These grants require two PIs – One must be a member of the Charles Perkins Centre:

One must be a University of Sydney or SHP Partner MRI employee

One from an SHP Health Service Partner

Key Dates:
Applications close: 3 July 2026, 5:00pm AEST
Successful applicants will be notified: August 2026
Grants will commence: from January 2027
SEE GRANT GUIDELINESSEE WEBSITE

MRFF National Critical Research Infrastructure
2026-07-14 17:00 (Australia/Sydney)
The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams.
Stream 1 – Innovation enablers
Address an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks, tissue repositories, novel platforms, and secure health data environments to create valuable research resources.
Stream 2 – Digitisation of health care
Translate or implement innovative artificial intelligence technologies into health applications that:

benefit multiple health disciplines/areas
involve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and
increase artificial intelligence workforce capacity and capability, particularly in relation to health, through cross-sector and interdisciplinary collaboration.

Stream 3 – Co-investment partnerships
Utilise co-investment (cash only) with the research sector, state and/or territory governments, and industry, in significant critical research infrastructure (e.g. facilities, personnel and equipment):

to support development of research capacity, capability and/or effectiveness in an area of unmet medical need, or
to enable Australian research using new platforms, systems and services in an area of unmet medical need.

Stream 4 – mRNA technology enablers
Leverage and enhance emerging mRNA technologies, platforms, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need.
Grants to fund research infrastructure projects, up to $3 million in Streams 1, 2 and 4, and up to $7 million in Stream 3.
An application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application.

Key Dates
Applications close: 14 July 2026
Indicative funding status: Funding anticipated to be awarded from December 2026
SEE GRANT GUIDELINESSEE WEBSITE

MRFF BioMedTech Incubator
2026-07-22 17:00 (Australia/Sydney)
The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators.
This grant is for an eligible organisation who can establish a working incubator, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development.
The 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative.
This opportunity looks to fund suitable organisations to identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential.
The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers, diagnostics, therapeutics, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation.
Applicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector).
Grants of up to $33 million to establish BioMedTech Incubators.

Key Dates
Applications close: 22 July 2026
Indicative funding status: Funding anticipated to be awarded from December 2026
SEE GRANT GUIDELINESSEE WEBSITE

NHMRC Investigator Grants
2026-07-29 17:00 (Australia/Sydney)
Investigator Grants provide the highest-performing researchers at all career stages with consolidated funding for their salary (if required) and a significant research support package.
In this way, the Chief Investigator has flexibility to pursue important new research directions as they arise, adjust their resources accordingly, and to form collaborations as needed, rather than being restricted to the scope of a specific research project.
Investigator Grants support:

Research across the 4 pillars of health and medical research: biomedical, clinical, public health and health services research.
All career stages: early career researchers, mid-career researchers and established researchers
Researchers with clinical responsibilities (such as clinicians, public health and allied health practitioners)
Full-time and part-time researchers.

Investigator Grants aim to:

Allow flexibility for investigators to pursue important new research directions as they arise and to form collaborations as needed
Foster innovative and creative research
Create opportunities for researchers at all career stages to establish their own research programs
Reduce application and peer review burden on researchers.

Key Dates:
Applications open: 3 June 2026
Minimum data due: 1 July 2026
Applications close: 29 July 2026
Proposed peer review: August – November 2026
Outcomes to be advised: March 2027
SEE GRANT GUIDELINESSEE WEBSITE

RACP Research Awards and Career Grants
2026-07-31 17:00 (Australia/Sydney)
Through the RACP Foundation, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships, scholarships and grants are available annually, totalling over $2.5 million in funding.
Career Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships.
Research Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career.
Research Entry Scholarships provide up to $45,000 stipend support to Advanced Trainees and Fellows who are at the start of their research careers, helping them undertake a Masters, PhD or equivalent higher degree and build a foundation for a future in medical research.
Research Development Grants provide from $10,000 to $30,000 in funding for smaller research projects for beginning researchers. Applicants can undertake a short-term or part-time research project.
Travel Grants provide from $10,000 to $30,000 funding to support RACP trainees and Fellows undertaking short periods of research, study or international collaboration.

Key Dates
Applications close:
Career Development & Research Establishment Fellowships: 30 June 2026
Research Entry Scholarships: 7 July 2026
Research Development Grants: 24 July 2026
Travel Grants: 31 July 2026
Outcomes advised: December 2026
SEE WEBSITE

MRFF Preventive and Public Health Research Initiative - 2026 Consumer-Led Research Grant
2026-08-05 17:00 (Australia/Sydney)
The Medical Research Future Fund (MRFF) – 2026 Consumer-Led Research Grant Opportunity will support research that:

Stream 1 (Incubator): identify health priorities, develop new approaches and/or methodologies and conduct pilot studies addressing health issues and/or barriers that:

are co-led, co-produced and/or co-designed with consumers
are in partnership with health services
increase consumers’ understanding of, and involvement in, research.

Stream 2 (Targeted Call for Research): develop and/or test scalable and sustainable approaches, in partnership with consumers, that enable self-care interventions or improve quality of life and/or survivorship care. Approaches are for individuals from one or more priority populations, who have experienced or are experiencing long term diseases and conditions. Approaches may, where appropriate, also deliver for the individual’s families, carers and communities.
Topic A: Research projects that focus on cancer
Topic B: Research projects that focus on long term physical diseases and conditions other than cancer
Topic C: Research projects that focus on mental health challenges, diseases or conditions.

The anticipated outcome of the research is to improve the health and wellbeing of Australians by:

Stream 1 (Incubator): developing effective approaches for addressing health priorities for communities and that build capability for consumer involvement in research
Stream 2 (Targeted Call for Research): developing effective approaches to improve the health and/or wellbeing for those who have experienced or are experiencing long term diseases and conditions

Key Dates:
Minimum data due: 8 July 2026
Applications close: 5 August 2026
SEE GRANT GUIDELINESSEE WEBSITE

MRFF Genomics Health Futures
2026-08-19 17:00 (Australia/Sydney)
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:
Stream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy.
Stream 2 (TCR): conduct scalable research to enhance novel gene discoveries, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies.
Stream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease, diabetes and other common and/or complex diseases).
Stream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer, colorectal cancer, prostate cancer and other common cancers)
Stream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice.
Stream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing, portability, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics.
Applicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan.
Key Dates

Minimum data due date: 22 July 2026
Applications close: 19 August 2026
Indicative funding status: Funding anticipated to be awarded from June 2027
SEE GRANT GUIDELINESSEE WEBSITE

MRFF EMCR Initiative - Early to Mid-Career Researchers Grant
2026-08-19 17:00 (Australia/Sydney)
The Medical Research Future Fund (MRFF) –2026 Early to Mid-Career Researchers Grant Opportunity will support research to build and grow research capacity and capability in Australia by supporting Early to Mid-Career Researchers (EMCRs) to continue their health and medical research careers.
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Stream 1 (Incubator): conduct early stage, small scale research, led by early career researchers, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.
Stream 2 (Accelerator): establish a large-scale interdisciplinary research program, led by mid-career researchers, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations.
Stream 3 (Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early or mid-career researchers into policy and practice. (Note: a priority population focus is not required).

The intended outcome of the research is to improve the health and wellbeing of Australians by:

Stream 1 (Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations.
Stream 2 (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.
Stream 3 (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice.

Key Dates:
Minimum data due: 22 July 2026
Applications close: 19 August 2026
Grant activity timeframe: February 2027
SEE GRANT GUIDELINESSEE WEBSITE

TOUR DE CURE Annual Grants
2026-08-21 17:00 (Australia/Sydney)
We are proud to open a new Annual Grants Round in 2026, made possible by the continued support of our community, partners, and fundraisers.
This year’s Grant Round is open to applications in the following categories:
• Early Career Research Grant
• PhD Scholarship
• Prof Richard Scolyer Award for Brain Cancer Research for Early, Mid and Senior Career Researchers
The Tour de Cure Grants Committee follows an ethical, independent, and transparent selection process when reviewing applications.
We are committed to funding innovation and excellence, using our resources to support the best Australian-based projects and researchers. As a cancer-agnostic organisation, we consider applications across all cancer types.
Demonstrating a rigorous selection process, choosing the strongest projects, and maintaining sound project governance – all grant applications are assessed on merit.
An EOI (Expression of Interest) is required for all research grant categories listed. EOIs are reviewed in Round One by the Tour de Cure Grants Committee. Successful applicants are then invited to submit a full grant application in Round Two, which is assessed in detail by the Grants Committee who then makes recommendations to the TDC Board for final decisions in December.
Institutions supporting individual researchers may submit no more than two applications per grant category. This limit applies even where an intermediary body, such as a foundation, applies on behalf of the researcher. There is no limit on the number of PhD Scholarship applications but please be mindful of your submission numbers.

Key Dates:
Expressions of Interest open: 1 August 2026
Expressions of Interest close: 21 August 2026
Expressions of Interest outcomes notified: 8 October 2026
Full grant applications open (by invitation): 9 October 2026
Full grant applications close: 24 October 2026
SEE GRANT GUIDELINESSEE WEBSITE

MRFF International Clinical Trial Collaborations
2026-09-16 17:00 (Australia/Sydney)
The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting.

The anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.
Please note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only.

Key Dates:
Minimum data due: 19 August 2026
Applications close: 16 September 2026
SEE GRANT GUIDELINESSEE WEBSITE

CDMRP Melanoma Research Program
2026-10-14 17:00 (America/Halifax)
The Melanoma Research Program (MRP) released program announcements for the following funding opportunities:

· Focused Program Award – Rare Melanomas
This award supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.
· Idea Award
The Idea Award supports innovative, exploratory, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding.
· Melanoma Academy Scholar Award
Supports the addition of independent, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful, highly productive melanoma researchers in a collaborative research and career development environment.
· Survivorship Research Award
The award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
· Team Science Award
Supports a broad range of hypothesis-driven, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex, multi-dimensional problems that will impact patient outcomes.
Key Dates:
Submission Deadline (Pre-application-Pre-Proposal): 13 July 2026
Focused Program Award – Rare Melanomas
Idea Award
Team Science Award
Submission Deadline (Pre-application-Pre-Proposal): 22 September 2026
Melanoma Academy Scholar Award
Survivorship Research Award
Application Submission Deadline: 14 October 2026

SEE GRANT GUIDELINESSEE WEBSITE

NHMRC Partnership Projects
2026-11-11 17:00 (Australia/Sydney)
The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice.

Partnership Projects create partnerships among decision makers, policy makers, managers, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery, organisation, funding and access to health services.
Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.
The objectives of the Partnership Project scheme are to:
• Meet the need for more effective integration of research evidence into health policy and service delivery
• Create partnerships among policy makers, managers, service providers and researchers
• Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care
• Be highly responsive to the priorities of government, the community and health professionals
• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

Key Dates for Peer Review Cycle 2:
Applications open: 19 March 2026
NHMRC-approved Administering Institutions waiver due: 8 July 2026
Minimum data due: 22 July 2026
Applications close: 5 August 2026
Peer review meetings: 17-19 November 2026
Key Dates for Peer Review Cycle 3:
Applications open: 23 July 2026
NHMRC-approved Administering Institutions waiver due: 14 October 2026
Minimum data due: 28 October 2026
Applications close: 11 November 2026
Peer review meetings: 2-4 March 2027
SEE GRANT GUIDELINESSEE WEBSITE

MRFF 2022 Frontier Health and Medical Research Grant
2027-03-31 17:00 (Australia/Sydney)
This grant program will support researchers to pursue big ideas to develop new products and interventions and implement these into clinical practice, benefiting patients, clinicians, and the health system.
This grant opportunity offers funding to support medical research and medical innovation programs of research (up to $25 million per program) that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re‑purpose existing health technologies in a novel way.
The initial application process to secure funding through this grant opportunity will be conducted in two stages:

expression of interest (EOI) – outlining a proposed program of research comprising of a series of linked projects with a 10-year time horizon
full application, (invitation only – following EOI) for a project of up to 5 years under the program of research.

Applicants may propose to commence research at any stage in the research pipeline from proof-of-concept, with the intention of achieving full implementation of the proposed technology in 10 years.
Funding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI). These applications may be submitted by invitation only.

Key Dates:
Expressions of Interest close: 31 March 2027
Last grants awarded by: 30 June 2028
SEE GRANT GUIDELINESSEE WEBSITE
